Rasha Cosman

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Jayesh Desai, Guzmán Alonso, Se Hyun Kim et al. · Nature Medicine · 2023 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab in patients with advanced solid tumors

Sophia Frentzas, Hui Gan, Rasha Cosman et al. · Cell Reports Medicine · 2023 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Abstract CT028: A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumors

Yonina R. Murciano‐Goroff, Rebecca S. Heist, Yasutoshi Kuboki et al. · Cancer Research · 2023 · 37 citations

Medicine, Oncology, Pharmacology +13

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Andrew R. Davidson, A.-S. Veillard, Annette Tognela et al. · Annals of Oncology · 2015 · 33 citations

Medicine, Oncology, Pharmacology +13

Patterns of care in adult medulloblastoma: results of an international online survey

Rasha Cosman, Chris Brown, Kevin C. De Braganca et al. · Journal of Neuro-Oncology · 2014 · 24 citations · Full text

Medicine, Oncology, Pediatrics +13